No Data
Chinese Health: Report for the third quarter of 2024
Huaren Health (301408.SZ) released its performance for the first three quarters, with a net income of 0.108 billion yuan, an increase of 22.62%.
Huaren Health (301408.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters reaching 3...
Anhui Huaren Health Pharmaceutical (SZSE:301408) Has A Pretty Healthy Balance Sheet
Anhui Huaren Health Pharmaceutical Co., Ltd.'s (SZSE:301408) Market Cap Increased by CN¥588m, Insiders Receive a 57% Cut
Shareholder Saifu Investment of Huaren Health (301408.SZ) plans to reduce its shareholding by up to 4 million shares.
Huarun Health (301408.SZ) announced that the shareholder Saifu Investment intends to reduce its shareholding in the company, with the specific number of shares to be reduced...
Chinese Health: Semi-Annual Report 2024
Could The Market Be Wrong About Anhui Huaren Health Pharmaceutical Co., Ltd. (SZSE:301408) Given Its Attractive Financial Prospects?No Data
No Data
